CORONAVIRUS/COVID-19 antibody detection kit granted emergency use authorization
Taipei, March 25 (CNA) A rapid COVID-19 antibody detection kit developed by researchers at Chang Gung University (CGU) recently received an emergency use authorization (EUA), paving the way for mass production, the university announced on Thursday.
The test kit, which was jointly developed along with Chang Gung Memorial Hospital, was authorized for use by Taiwan's Food and Drug Administration (FDA) on March 5, the university said in a statement.
According to the university, the kit uses samples of blood serum to measure the potency of neutralizing antibodies in a person who has been vaccinated against COVID-19 and can produce results with 90 percent accuracy in 1.5 hours.
Chiu Cheng-hsun (邱政洵), deputy superintendent of Linkou Chang Gung Memorial Hospital, said the tests will be vital until such time as the world reaches herd immunity to COVID-19, as they can confirm whether or not a person is adequately protected from infection.
For example, he said, if people arriving in Taiwan could present a negative PCR test, proof of vaccination and also show the presence of neutralizing antibodies, this would offer a high degree of certainty that there was no risk of them spreading or contracting the virus.
In such a scenario, it would be possible to consider shortening or even removing the quarantine requirement for incoming travelers, which would help the country re-open its border and resume various kinds of international exchanges, he said.
According to Shih Shin-ru (施信如), director of the university's Research Center for Emerging Viral Infections, the traditional method of testing for neutralizing antibodies involves placing blood serum along with virus-infected cells to see if the virus is suppressed.
The entire process takes three to five days and as it involves the cultivation of viruses, has to be carried out in a biosafety level 3 lab, she said.
Biosafety levels are used to identify the protective measures needed in a laboratory setting to protect workers, the environment and the public.
However, the test kit developed by CGU, which uses a specialized protein to detect the neutralizing antibodies of the virus that causes COVID-19, can be used in any laboratory, Shih said.
The technology for the antibody detection kit has been licensed to Formosa Biomedical Inc. and with the FDA's authorization, will soon enter mass production, the university said.
- Taiwan reports one new imported COVID-19 caseTaiwan on Monday reported one new imported case of COVID-19, bringing the total number of cases in the country to 1,058, according to the Central Epidemic Command Center (CECC).04/12/2021 03:14 PM
- Taiwan reports 11th COVID-19 death, 1 new imported caseTaiwan on Sunday confirmed one death from COVID-19, bringing the total to 11 in the country since the outbreak began, and one new imported case, according to the Central Epidemic ...04/11/2021 05:41 PM
- Taiwan reports 2 new imported COVID-19 casesTaiwan has added two new imported COVID-19 cases, one from Indonesia and the other from the Philippines, bringing the number of confirmed cases in the country to date to 1,056, ...04/10/2021 03:59 PM
25 PLA planes fly through Taiwan's ADIZ on Monday, most this year04/12/2021 10:36 PM
- Science & Tech
Taiwanese researchers suggest new treatment for COVID-19: study04/12/2021 09:54 PM
Taiwan voices concerns over Japan's plan to dump radioactive water04/12/2021 09:27 PM
Drought at Techi Reservoir persists, threatening water supply04/12/2021 09:13 PM
Proposed amendments list 'acts of omission' as form of animal abuse04/12/2021 08:37 PM